Memory Pharmaceuticals: Clinical Trials

3 completed, 2 unknown. 5 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	5	Completed 3, Unknown 2

Follow Memory Pharmaceuticals: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients MEM 3454, Placebo for MEM 3454 - Schizophrenia	Phase 2	Unknown	Memory Pharmaceuticals	12	2008-08-01	2008-07-31
Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia MEM 3454, Placebo for MEM 3454 - Cognitive Impairment Associated With Schizophrenia	Phase 2	Unknown	Memory Pharmaceuticals	160	2007-12-01	2008-12-08
Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease MEM 3454 - Alzheimer's Disease	Phase 2	Completed	Memory Pharmaceuticals	80	2007-02-01	2008-05-06
Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder MEM 1003 - Bipolar Disorder With Manic or Mixed Episodes	Phase 2	Completed	Memory Pharmaceuticals	60	2006-09-01	2008-05-06
Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease MEM 1003, Placebo for MEM 1003 - Alzheimer's Disease	Phase 2	Completed	Memory Pharmaceuticals	183	2005-11-01	2008-05-06

Conditions studied

Alzheimer Disease (2)  ·  Cognitive Dysfunction (2)  ·  Mania (1)  ·  Schizophrenia (1)

Countries

United States (5)

Top investigators

Stephen R Murray, MD, PhD (2)  ·  Ann Olincy, MD, MPH (1)  ·  Stephen Murray, MD, PhD (1)